Reporting of PPI and the MCID in phase III/IV randomised controlled trials —a systematic review

ConclusionsPPI and the MCID are poorly reported, so it is uncertain how these contributed to trial design. Improvement in the reporting of these items would increase confidence that results are relevant and clinically significant to patients, contributing to improving the overall trial design.Trial registrationNot registered.
Source: Trials - Category: Research Source Type: clinical trials